228 related articles for article (PubMed ID: 30843252)
1. The clinical significance of HOXA9 promoter hypermethylation in head and neck squamous cell carcinoma.
Zhou C; Li J; Li Q; Liu H; Ye D; Wu Z; Shen Z; Deng H
J Clin Lab Anal; 2019 Jun; 33(5):e22873. PubMed ID: 30843252
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation biomarkers for head and neck squamous cell carcinoma.
Zhou C; Ye M; Ni S; Li Q; Ye D; Li J; Shen Z; Deng H
Epigenetics; 2018; 13(4):398-409. PubMed ID: 29927694
[TBL] [Abstract][Full Text] [Related]
3.
Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
[TBL] [Abstract][Full Text] [Related]
4. CpG islands in MyD88 and ASC/PYCARD/TMS1 promoter regions are differentially methylated in head and neck squamous cell carcinoma and primary lung squamous cell carcinoma.
Šutić M; Baranašić J; Bilić LK; Bilić M; Jakovčević A; Brčić L; Seiwerth S; Jakopović M; Samaržija M; Zechner U; Knežević J
Diagn Pathol; 2021 Feb; 16(1):17. PubMed ID: 33637109
[TBL] [Abstract][Full Text] [Related]
5. HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/β-catenin signaling axis.
Lee K; Chang JW; Oh C; Liu L; Jung SN; Won HR; Kim YI; Rha KS; Koo BS
Eur J Surg Oncol; 2020 Jun; 46(6):1066-1073. PubMed ID: 31864826
[TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
[TBL] [Abstract][Full Text] [Related]
7. Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue.
Bhat S; Kabekkodu SP; Jayaprakash C; Radhakrishnan R; Ray S; Satyamoorthy K
Virchows Arch; 2017 Apr; 470(4):445-454. PubMed ID: 28255813
[TBL] [Abstract][Full Text] [Related]
8. The Association and Clinical Significance of CDKN2A Promoter Methylation in Head and Neck Squamous Cell Carcinoma: a Meta-Analysis.
Zhou C; Shen Z; Ye D; Li Q; Deng H; Liu H; Li J
Cell Physiol Biochem; 2018; 50(3):868-882. PubMed ID: 30355925
[TBL] [Abstract][Full Text] [Related]
9. Methylated genomic loci encoding microRNA as a biomarker panel in tissue and saliva for head and neck squamous cell carcinoma.
Cao Y; Green K; Quattlebaum S; Milam B; Lu L; Gao D; He H; Li N; Gao L; Hall F; Whinery M; Handley E; Ma Y; Xu T; Jin F; Xiao J; Wei M; Smith D; Bornstein S; Gross N; Pyeon D; Song J; Lu SL
Clin Epigenetics; 2018; 10():43. PubMed ID: 29636832
[TBL] [Abstract][Full Text] [Related]
10. The Clinical Signification of Claudin-11 Promoter Hypermethylation for Laryngeal Squamous Cell Carcinoma.
Shen Z; Cao B; Lin L; Zhou C; Ye D; Qiu S; Li Q; Cui X
Med Sci Monit; 2017 Jul; 23():3635-3640. PubMed ID: 28743857
[TBL] [Abstract][Full Text] [Related]
11. Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene.
Tawfik HM; El-Maqsoud NM; Hak BH; El-Sherbiny YM
Am J Otolaryngol; 2011; 32(6):528-36. PubMed ID: 21353335
[TBL] [Abstract][Full Text] [Related]
12. Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer.
Schmitt K; Molfenter B; Laureano NK; Tawk B; Bieg M; Hostench XP; Weichenhan D; Ullrich ND; Shang V; Richter D; Stögbauer F; Schroeder L; de Bem Prunes B; Visioli F; Rados PV; Jou A; Plath M; Federspil PA; Thierauf J; Döscher J; Weissinger SE; Hoffmann TK; Wagner S; Wittekindt C; Ishaque N; Eils R; Klussmann JP; Holzinger D; Plass C; Abdollahi A; Freier K; Weichert W; Zaoui K; Hess J
Int J Cancer; 2019 Dec; 145(12):3299-3310. PubMed ID: 31135957
[TBL] [Abstract][Full Text] [Related]
13. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma.
Chaisaingmongkol J; Popanda O; Warta R; Dyckhoff G; Herpel E; Geiselhart L; Claus R; Lasitschka F; Campos B; Oakes CC; Bermejo JL; Herold-Mende C; Plass C; Schmezer P
Oncogene; 2012 Dec; 31(49):5108-16. PubMed ID: 22286769
[TBL] [Abstract][Full Text] [Related]
15. High P4HA1 expression is an independent prognostic factor for poor overall survival and recurrent-free survival in head and neck squamous cell carcinoma.
Li Q; Shen Z; Wu Z; Shen Y; Deng H; Zhou C; Liu H
J Clin Lab Anal; 2020 Mar; 34(3):e23107. PubMed ID: 31782831
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic silencing of
Misawa K; Mochizuki D; Imai A; Misawa Y; Endo S; Mima M; Kawasaki H; Carey TE; Kanazawa T
Clin Epigenetics; 2017; 9():64. PubMed ID: 28616099
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma.
Guo YZ; Sun HH; Wang XT; Wang MT
J Zhejiang Univ Sci B; 2018 Sept.; 19(9):674-688. PubMed ID: 30178634
[TBL] [Abstract][Full Text] [Related]
18. Rh type C-glycoprotein functions as a novel tumor suppressor gene by inhibiting tumorigenicity and metastasis in head and neck squamous cell carcinoma.
Xu W; Zou H; Wei Z; Song C; Tang C; Yin X; Wang Y; Han S; Cai Y; Han W
Aging (Albany NY); 2019 Jun; 11(11):3601-3623. PubMed ID: 31170090
[TBL] [Abstract][Full Text] [Related]
19. Correlation of gene methylation in surgical margin imprints with locoregional recurrence in head and neck squamous cell carcinoma.
Hayashi M; Wu G; Roh JL; Chang X; Li X; Ahn J; Goldsmith M; Khan Z; Bishop J; Zhang Z; Zhou XC; Richmon J; Agrawal N; Koch WM
Cancer; 2015 Jun; 121(12):1957-65. PubMed ID: 25773145
[TBL] [Abstract][Full Text] [Related]
20. Validation of nucleolar protein 4 as a novel methylated tumor suppressor gene in head and neck cancer.
Demokan S; Chuang AY; Pattani KM; Sidransky D; Koch W; Califano JA
Oncol Rep; 2014 Feb; 31(2):1014-20. PubMed ID: 24337411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]